-
<![CDATA[Fixed-Duration Elranatamab Consolidation Enhances MRD-Negativity Following CAR T Therapy]]>
24 Sep 2025 00:43 GMT
… 25% present with high-risk cytogenetics (del[17p], t[4;14 …
-
<![CDATA[Linvoseltamab Adds Highly Effective Option in Later-Line Multiple Myeloma]]>
23 Sep 2025 15:49 GMT
… with extramedullary disease, high-risk cytogenetics, and high baseline BCMA levels …
-
<![CDATA[AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights]]>
22 Sep 2025 20:43 GMT
… 3 disease with high-risk cytogenetics (t(4;14), del(17p …
-
Chromosome Barcoding Brings Precision to Tropical Fruit Genetics
22 Sep 2025 17:50 GMT
… plays a central role in cytogenetics, helping to reveal evolutionary processes …
-
<![CDATA[Belantamab Mafodotin/Lenalidomide Maintenance Displays Manageable Eye Toxicity Profile in Newly Diagnosed Myeloma]]>
21 Sep 2025 01:48 GMT
… benefitted patients with high-risk cytogenetics. In total, 30.4% of … patients had high-risk cytogenetics. Best responses in these patients …
-
<![CDATA[BKd Produces Robust Responses in Relapsed/Refractory Multiple Myeloma]]>
21 Sep 2025 01:48 GMT
… prognostic factors, including high-risk cytogenetics (P = .0691), number of prior …
-
<![CDATA[IMS 2025: Daratumumab Plus Lenalidomide Improves Outcomes in Post-Transplant Maintenance for Myeloma]]>
20 Sep 2025 17:26 GMT
… stratified based on high-risk cytogenetics. Patients had received a median … 17p deletion and high-risk cytogenetics in the DR subgroup.
Despite …
-
<![CDATA[Isa-VRd Meets Primary End Point in Transplant-Ineligible Newly Diagnosed Multiple Myeloma]]>
20 Sep 2025 20:09 GMT
… , and 86% had standard risk cytogenetics.
Any grade adverse effects (AEs …
-
<![CDATA[AML Survival After 3 Years in Remission Comparable With General Population]]>
20 Sep 2025 20:11 GMT
… groups was 59 years
Diploid cytogenetics was seen in 48% of …
-
<![CDATA[ATLAS Analysis Supports KRd After ASCT in High-Risk, Newly Diagnosed Myeloma]]>
20 Sep 2025 19:49 GMT
… .6%) and had standard-risk cytogenetics (76.1%; 79.5%). Disease …